Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)

Autor: Wedner, H. James, Aygören-Pürsün, Emel, Bernstein, Jonathan, Craig, Timothy, Gower, Richard, Jacobs, Joshua S., Johnston, Douglas T., Lumry, William R., Zuraw, Bruce L., Best, Jessica M., Iocca, Heather A., Murray, Sharon C., Desai, Bhavisha, Nagy, Eniko, Sheridan, William P., Kiani-Alikhan, Sorena
Zdroj: In The Journal of Allergy and Clinical Immunology: In Practice June 2021 9(6):2305-2314
Databáze: ScienceDirect